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Background: Simple and sensitive spectrophotometric method is described based on the reaction of drug
(gabapentin) with ninhydrin in pure form and in pharmaceutical preparations.
Methods: Complex formed during this reaction is measured at 575 nm as a function of time. Kinetic study involve
initial-rate, rate-constant and fixed-time (80 minutes) procedures to determine the concentration of the drug.
Results: Drug was studied in the concentration range of 10-30 μgmL-1 showing correlation coefficient 0.9997,
0.9970 and 0.9990 for initial rate, rate constant and fixed time respectively. Limit of detection (LOD) and limit of
quantification (LOQ) was found to be 0.13 and 0.04 nana grams respectively. The variables affecting the reactions
were optimized and the developed method was validated according to ICH guidelines.
Conclusion: The proposed method has been efficiently applied to the estimation of gabapentin in pharmaceutical
formulation with first-class recovery (98.3-101.4%). Thermodynamic parameters were studied i.e., association
constants and standard free energy changes were determined by Benesi–Hildebrand equation while, Gibbs free
energy change for the complex was also estimated.
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The new anti-convulsant drug gabapentin (1-
(aminomethyl)cyclo-hexaneacetic acid) is a GABA
analogue. It was originally developed for the treatment
of epilepsy, and currently, gabapentin is widely used to
relieve pain, especially neuropathic pain, it is indicated
in the treatment of epilepsy and neuropathic pain, also
in the treatment of bipolar disorder and may be effective
in reducing pain and spasticity in multiple sclerosis.
Gabapentin is a γ-aminobutyric acid (GABA) analogue
that does not bind to GABA receptors or alter GABA
metabolism in the brain (Goldlust et al. 1995). Its action
is attributed to the irreversible inhibition of the enzyme
GABA-transaminase, thus preventing the physiological
degradation of GABA in the brain (Ouellet et al. 2001).
Analytical methods reported for its determination* Correspondence: farhanchemist@gmail.com
1Faculty of Pharmacy, Federal Urdu University Arts, Science and Technology,
Karachi 75300, Pakistan
Full list of author information is available at the end of the article
© Siddiqui et al.; licensee Springer. This is
Attribution License (http://creativecommons.or
in any medium, provided the original work is p
2013consist of high-performance liquid chromatography
(HPLC) (Jiang & Li 1999; Tang et al. 1999; Chollet et al.
2000; Ifa et al. 2001; Ratnaraj & Patsalos 1998; Wad &
Kramer 1998), spectrofluorimetry (Belal et al. 2002;
Hassan et al. 2001), gas chromatography–mass spec-
trometry (GC–MS) (Kushnir et al. 1999; Van Lentea &
Gatautis 1998), capillary electrophoresis (Rada et al.
1998) and spectrophotometry applying Hantzsch reac-
tion (al-Zehouri et al. 2001). So far, no traces of any at-
tempts have been found for determination of gabapentin
by colorimetric method and the literature is still starving
for such analytical procedures. There are number of
methods for determination of gabapentin in literature
(Manera et al. 2009; Lin et al. 2004; Jia et al. 2012;
Ribeiro et al. 2007; Abdulrahman & Basavaiah 2011;
Abdulrahman & Basavaiah 2012; Jalali et al. 2007; Hegde
et al. 2009; Patel et al. 2011; Siddiqui et al. 2010).
Reactions with ninhydrin (NIN) has been widely used
to analyze and characterize amino acids, thiophen and
proteins as well as numerous other NIN positivean open access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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chemical, microbiological, nutritional and plant studies
(Friedman 2004). It has been extensively used in the de-
termination of the compounds of pharmaceutical im-
portance applied to their kinetic studies (Rahman &
Azmi 2001a; Campins-Falco et al. 1996; Arayne et al.
2008). Present study describes a direct, sensitive and
precise spectrophotometric method simpler than the
existing UV and HPLC methods that is free from such
experimental variables as extraction step for the deter-
mination of gabapentin in reference material and
pharmaceutical formulations by means of developing
charge transfer complex with NIN.
No interference was observed in the assay of
gabapentin from common excipients in levels found in
pharmaceutical formulations. The method rely on the
use of simple and inexpensive technique but give out
sensitivity analogous to that procured by sophisticated
and expensive techniques such as HPLC, and are vali-
dated as per ICH recommendations (ICH Topic Q2(R1)
2005). The kinetic approach for determining gabapentin
in commercial dosage form, using NIN as a reagent,
confer simplicity and rapidity as the procedure simply
require heating and cooling of the reaction mixture.
During this study the reaction conditions and applica-
tion of the methods for determination of gabapentin in
pharmaceutical formulations have been established, in
addition, the association constant, stoichiometric ratio of
reactants and the standard free energy changes (ΔG°)
were determined.
Our present study suggests kinetic and thermo-
dynamic spectrophotometric procedure for the deter-
mination of gabapentin in pharmaceutical formulations.
The methods are based on the reaction of primary
amino group of gabapentin with NIN.
Experimental
Apparatus
Shimadzu 1601 double beam UV–visible spectropho-
tometer possessing a fixed slit width (2 nm) with quartz
cells of 10 mm path length connected to a PIV computer
loaded with Shimadzu UVPC version 3.9 software were
used to record the absorption spectra.
Materials and reagents
All reagents were of analytical grade. Gabapentin pure
drug was obtained from Godecke AG, Darmstadt,
Germany under license of Park-Davis (Pvt.) Ltd. Karachi,
Pakistan. Gabin® capsules 200 mg (PharmEvo Pharma-
ceutical Company (Pvt.) Ltd., Karachi, Pakistan), Gaba®
capsules 100 mg (Nabi Qasim Pharmaceuticals (Pvt)
Ltd., Karachi, Pakistan), Gabaplus® capsules 100 mg
(Platinum Pharma (Pvt.) Ltd., Karachi, Pakistan) and
Neupentin® capsules 400 mg (Highnoon Pharma (Pvt.)Ltd., Karachi, Pakistan) were purchased from the market.
Ninhydrin was purchased from Merck Schuchardt
OHG, Darmstadt, Germany. HPLC grade methanol was
from fisher scientific UK.
General procedure
Preparation of standard stock solutions
Solution of 0.1 mgmL−1 gabapentin was prepared in
water by dissolving 10 mg of gabapentin in 100 mL of
purified water and stored in a cool (<25°C) and dark
place. Ninhydrin reagent was 2 mgmL−1 in methanol
and was prepared fresh daily.
Method
Aliquots of 1 mL of stock solution corresponding to 100
μgmL-1 of gabapentin were transferred into heating
tubes. 2 mL of 1% NIN solution was added and heated
on boiling water bath for 2 hours, after cooling the mix-
ture was transferred into 25 mL volumetric flask and di-
luted to volume with distilled water. Increase in
absorbance at 575 nm was recorded as a function of
time against the reagent blank at room temperature
(spectra 1). The initial rate of reaction at different con-
centrations was calculated from the initial slope of ab-
sorbance time curve. The calibration curves were
constructed by plotting logarithm of initial-rate of reac-
tion versus logarithm of molar concentration, rate-
constant versus final concentration and absorbance mea-
sured at a fixed-time versus final concentration of
gabapentin.
Procedures for pharmaceuticals formulation
Twenty capsules of each formulation were weighed and
powdered. The powder equivalent to 10 mg of
gabapentin was dissolved in 100 mL of water to give
0.1 mg mL-1 of gabapentin. The procedure was contin-
ued as described under general procedures.
Stoichiometric study
Job’s method of continuous variation (Rose 1964) was
employed. Master equimolar solution of gabapentin was
prepared in water whereas NIN was prepared in metha-
nol and made up to volume with the same solvent. A
series of 10 mL portions of master solution of
gabapentin with NIN was made up comprising different
complementary proportions (0:10, 1:9, 2:8……9:1) in 10-
mL calibrated flasks. The absorbance of the resulting so-
lutions were measured at the wavelength of maximum
absorption after the appropriate time against reagent
blanks treated similarly.
Interference from excipients
Samples were prepared by mixing 50 mg of gabapentin
with various amounts of common excipients such as
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rolidone, HPMC (hydroxypropylmethylcellulose) and
starch. The procedure was continued as described under
general procedures.
Results and discussion
Gabapentin exhibits a very low UV absorption, with
A1%1cm at 276 nm = 6.5 (Abdellatef & Khalil 2003) and as a
result poor sensitivity will be achieved by conventional
UV spectrophotometric methods. There was a critical
need to develop a spectrophotometric method that could
quantitate gabapentin in pharmaceutical formulations.
Reaction with Ninhydrin (NIN)
Ninhydrin reagent is used for the determination of an
aliphatic primary amine or an amino acid group (Fried-
man 2004; Rahman & Azmi 2001a; Campins-Falco et al.
1996; Arayne et al. 2008; Rahman & Azmi 2001b;
Nobrega Jde et al. 1994; Molnar-Perl & Pinter-Szakacs
1989). The presence of an aromatic ring exhibits the re-
sponse; the exhibition increases if the amino group is
nearer to the ring. The end product of NIN reaction
with amino acid (Ruhemanns purple) give best color in
methanol, however water can be used as good option in
case when extraction of the active molecule is
compromised. The reaction mixture is heated for a short
while and is measured at maximum wavelength 568 nm
which is dependent on solvent system and reaction con-
dition (Görög 1995).
Gabapentin interacts with NIN in pure methanol via
oxidative deamination of the primary amino groupFigure 1 Absorption spectra of the reaction products of gabapentin wfollowed by the condensation of the reduced NIN to
form the purple colored reaction complex with λmax at
575 nm (Figures 1 and 2).
Gabapentin was found to be competent of reacting
with NIN only at higher temperatures. Maximum color
was obtained by heating on a water bath at 70 ± 5°C for
80 minutes. Prolonged heating decreased the chromo-
genic intensity, so the reaction time should be con-
trolled. Different solvents such as water, ethanol,
methanol, isopropanol, and acetonitrile have been tried,
but the best results were obtained with methanol.Optimization of reaction
The reaction between gabapentin and ninhydrin in
methanol resulted in the formation of blue colored com-
plex. At 70°C, the intensity of color increased with time
and became stable after 80 minutes.Kinetic studies
Initial rate method In order to study the kinetic param-
eters of the proposed reactions, the initial rate of the re-
action was determined by using time curve (from the
measurement of the slope of the initial tangent to the
absorbance). Concentration of NIN was kept constant
and the reaction was studied at different concentrations
of gabapentin to establish the order of reaction with re-
spect to gabapentin. For each run, a plot of log A¥/A¥–
At versus time was a straight line indicating a first order
reaction. The first order rate constant was also estimated
from the slopes of the above plot.ith NIN.
OH
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O
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Figure 2 Suggested reaction pathway between gabapentin and NIN.
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NIN, all subsequent investigations were conducted with
fixed concentration of gabapentin and varied concentra-
tions of NIN. The first order kinetics was also confirmed
by plot of log A¥/A¥–At versus time. The initial rate of
reaction under pseudo-first order conditions would obey
the following equation:
Rate ¼ dA=dt ¼ k0Cn
Where, “k'” is the pseudo-first order rate constant, “C”
is the concentration of gabapentin, “n” is the order of re-
action. The above equation may be written in the loga-
rithmic form as,
Log rate ¼ log k0 þ n log C
Linear regression analysis was used to calculate slope,
intercept and correlation coefficient (Table 1). The re-
gression of log rate versus log C gave a linear regression
equation,
Log rate ¼ log k0 þ 0:01018 log C
The value of “n” in the regression equation also indi-
cated the first order reaction with respect to gabapentin
concentration. The calibration curve constructed in the
range of 10-30 μgmL-1 (absorbance of different concen-
trations of gabapentin versus time) showed a linear
relationship.
Rate-constant method The rate constant values analo-
gous to different concentrations of gabapentin were cal-
culated by plotting the slopes of log A¥/A¥–At versus
time under pseudo-first order conditions (Table 2). The
calibration graph was constructed by plotting rate con-
stant against the concentration of gabapentin, and a lin-
ear response in the concentration range of 10-30 μgmL-1
were observed. Consequent data is presented in Table 2.Table 1 Statistical and regression data of proposed
method
Initial Rate Rate Constant Fixed Time
Intercept 0.0021 −0.22284 −0.0028
Slop 0.01018 0.014626 0.0129
r2 0.9994 0.9990 0.9999
Correlation coefficient (r) 0.9997 0.9970 0.9990Fixed time method A single concentration of
gabapentin was monitored at 575 nm against reagent
blank at a pre selected fixed time. A plot of absorbance
versus initial concentration of gabapentin was calibrated
at fixed time (20, 40, 60 and 80 minutes). Regression
equations were developed keeping working standards in
view and important analytical parameters have been cal-
culated (Table 3) which were found to be in acceptable
limits for correlation coefficient, intercept and slope at
all fixed time. It is hence suggested that any fixed time
can be used for assay of gabapentin.
The high values of correlation coefficients resulting
from regression equations demonstrate reliable linearity
of the methods. The values of slopes of the regression
equations of the proposed methods indicate good sensi-
tivity. The small values of the standard deviation address
the precision of the calibration data points around the
line of regressions for all the proposed procedures. Inde-
pendent repeatability studies were performed of the pro-
posed methods with five replicates for each method
(Table 4). The obtained data shows that the methods
can be applied to dosage formulations with accuracy and
precision (Table 5).
Stoichiometry of the reaction
On observing the molar ratio of the gabapentin with
NIN using Job’s method of continuous variation (Rose
1964), it was found to be 1:2 for NIN.
Thermodynamic studies
Association constants and standard free energy changes
The association constants were determined for the inter-
action of gabapentin with NIN using Benesi–Hildebrand
equation (Benesi & Hidelbrand 1949) was 1.418 × 103.
Ca
A
¼ 1
ε
þ 1
Kc ⋅ ε
: 1
Cb
:
Table 2 Method of rate constantConcentration μgmL-1 Calculated Value of Rate Const
(slope) Min-1
10 0.0147
14 0.0146
18 0.0146
20 0.0146
30 0.01463
Table 3 Regression characteristics of gabapentin
concentration at different time interval
(Fixed Time) 20 40 60 80
Intercept −0.002 −0.0022 −0.0034 −0.0036
Slope 0.0112 0.0124 .0114 0.0115
Correlation coefficient (r) 0.9990 0.9992 0.9998 0.9999
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and donor respectively, A is the absorbance of the com-
plex, ε is the molar absorptivity of the complex and Kc is
the association constant of the complex.
Straight line was obtained by plotting Ca versus A and
Gibbs Free energy change for the complex was calcu-
lated to be (-4.947) by using equation as given below
(Martin et al. 1969).
ΔG ¼ −2:303 R T log KC
Where ΔG° is the free energy change of the complex
(kJ mol−1), R the gas constant (1.987 cal mol−1 deg−1), T
the temperature in Kelvin (273 +°C) and Kc is the associ-
ation constant of drug-acceptor complexes (1 mol−1).
Linearity, accuracy and precision
Linearity, accuracy and precision were assessed for the
method in the range of 10 to 30 μgmL-1. Regression sta-
tistics were calculated for the colorimetric procedures
and linear regression plots showed the directly propor-
tional relationship of absorbance over Beer’s law range
given in Tables 1 and 4. The table also shows the results
of the statistical analysis of the experimental data, such
as the slopes, the intercepts, the Square of correlation
coefficients obtained by the linear least-squares treat-
ment of the results.
Five different concentrations of gabapentin were pre-
pared, each solution was analyzed in five replicate to
evaluate the accuracy and precision of the methods.. The
mean Standard Deviation and% relative standardTable 4 Accuracy and precision of proposed method
Initial Rate
Amount Found % Recover Found
10 10.05 100.5 9.96
14 14.14 101 13.95
18 18.22 101.22 18.17
20 19.86 99.3 20.22
30 30.41 101.36 29.85
Mean 100.6778
STD 0.837361
RSD 0.831723
STD = Standard deviation, RSD = Relative standard deviationdeviation (%RSD) as depicted in Table 4 were found to
be in the acceptable range of (0.0793 – 0.8376) and
(0.494 – 0.8317) respectively.
It was observed that at specific wavelength the absorp-
tion intensity was dependent upon the concentration of
gabapentin. It was observed that Beer’s law was followed
in all cases with very small range of intercept values
(-0.0028 to 0.0021) and slopes ranged from (0.01018 to
0.0146) for the concentration ranges as described in
Table 1. The correlation coefficient values were found to
be in the range of 0.9970 – 0.9997 using the least-square
method.
Specificity
The interference of excipients, additives and other sub-
stances present in formulation and the affect of degrad-
ation products of gabapentane on the proposed method
were experimentally observed. Ionization potential of
the donor and the electron affinity of the acceptor are
the two main parameters which influenced the energy of
complex. The basic nature of gabapentin due to charge
transfer is responsible for its specificity to the reaction.
Hence a degradation product of gabapentin does not
have specificity for the reaction as they lack the basicity.
The percentage recoveries as shown in Table 6 con-
firmed that there was no interference from any excipient
present in the formulation for the proposed method.
Limit of detection (LOD) and limit of quantification (LOQ)
The theoretically determined values of LOD and LOQ
for gabapentin with NIN were cross checked by actual
analysis of these concentrations using proposed
methods. LOD of gabapentin with NIN 0.04 μg mL−1
while LOQ were 0.13 μg mL−1.
Analysis of pharmaceutical dosage forms
The determination of gabapentin in formulation was car-
ried out using the proposed charge transfer
spectrophometric method along with the referenceRate Constant Fix Time
% Recover Found % Recover
9.96 10.1 101
9.96 14.15 101
10.09 17.98 99.8
10.11 20.2 101
9.98 30.17 100
10.01575 100.70
0.079303 0.4987
0.791779 0.494
Table 5 Determination of gabapentin in pharmaceuticals formulations by proposed
Ini. Rate Rate Constant Fix Time Reference method
Gabaplus 100 mg cap (Platanium)
Taken Found %Rec Found %Rec Found %Rec Found %Rec
100 100.78 100.78 99.38 99.38 101.30 101.3 99.2 99.2
100 99.540 99.54 100.84 100.84 98.88 98.88 101.4 101.4
100 101.230 101.23 98.41 98.41 99.40 99.4 100.66 100.66
100 98.670 98.67 101.28 101.28 100.66 100.66 98.3 98.3
100 100.230 100.23 99.63 99.63 99.30 99.3 100.7 100.7
Mean 100.090 100.09 99.91 99.908 99.91 99.908 100.05 100.052
STD 1.014 1.01417 1.16 1.15662 1.02 1.023191 1.27 1.26512
RSD 1.013 1.013263 1.16 1.157685 1.024133 1.024133 1.264459 1.26446
T-Test 0.72 0.83 0.94
F-Test 1.26 1.39 1.05
Gabin 200 mg cap (PharmEvo)
Taken Found %Rec Found %Rec Found %Rec Found %Rec
200 201.300 100.65 202.20 101.1 199.30 99.65 202.2 101.1
200 200.680 100.34 199.30 99.65 201.50 100.75 197.9 98.95
200 198.950 99.475 198.80 99.4 200.80 100.4 198.6 99.3
200 199.200 99.6 201.30 100.65 201.40 100.7 200.6 100.3
200 198.300 99.15 200.80 100.4 199.40 99.7 200.6 100.3
Mean 199.686 99.843 200.48 100.24 200.48 100.24 199.98 99.99
STD 1.254 0.627092 1.41 0.704805 1.07 0.533151 1.73 0.86342
RSD 0.628 0.628079 0.70 0.703117 0.531875 0.531875 0.86351 0.86351
T-Test 0.68 0.94 0.73
F-Test 1.25 1.48 1.17
Neupentin 400 mg cap (Highnoon)
Taken Found %Rec Found %Rec Found %Rec Found %Rec
400 400.800 100.2 398.40 99.6 398.50 99.625 402.87 100.718
400 402.100 100.525 397.50 99.375 401.20 100.3 400.96 100.24
400 398.600 99.65 401.50 100.375 400.90 100.225 397.5 99.375
400 399.400 99.85 402.80 100.7 401.20 100.3 398.2 99.55
400 398.200 99.55 398.80 99.7 400.90 100.225 404.3 101.075
Mean 399.820 99.955 399.80 99.95 400.54 100.135 400.77 100.192
STD 1.616 0.404042 2.24 0.56097 1.15 0.287554 2.92 0.73106
RSD 0.404 0.404224 0.56 0.561251 0.287167 0.287167 0.729663 0.72967
T-Test 0.74 0.68 0.84
F-Test 1.39 1.47 1.14
Gaba 100 mg cap (NabiQasim)
Taken Found %Rec Found %Rec Found %Rec Found %Rec
100 101.200 101.2 98.58 101.2 101.33 101.33 101.2 101.2
100 99.800 99.8 99.64 99.8 99.66 99.66 98.96 98.96
100 100.600 100.6 110.80 100.6 98.44 98.44 99.47 99.47
100 100.700 100.7 100.33 100.7 101.30 101.3 100.22 100.22
100 99.500 99.5 101.20 99.5 100.66 100.33 99.32 99.32
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Table 5 Determination of gabapentin in pharmaceuticals formulations by proposed (Continued)
Mean 100.360 100.36 100.11 100.36 100.28 100.278 99.83 99.834
STD 0.695 0.694982 1.03 0.694982 1.23 1.230577 0.89 0.8919
RSD 0.692 0.692489 1.03 0.692489 1.227166 1.227166 0.892481 0.89248
T-Test 0.65 0.88 0.94
F-Test 1.37 1.62 1.08
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ples. Similar accuracy and precision were observed for
the calculated and theoretical values (95% confidence) of
the proposed and official methods as no remarkable dif-
ference was observed for the t and F tests. From Table 5
it is apparent that the present method can be followed
for the analysis of these drugs in their single dosage
forms. The recoveries in the range from 98.3 to 101.4%
clearly showed no interference of any excipients of
formulation.
Spectroscopic studies
Infrared spectra
The IR spectra of gabapentin+Nin Complex showed nei-
ther the expected doublet of primary NH2 in the region
3200 – 3400 cm-1 nor the usual carbonyl stretch of
COOH near 1710 cm-1. Instead multiple peaks were ob-
served in the region 2500 – 3000 cm-1 that can be at-
tributed to ammonium ion (NH3
+), the asymmetric and
symmetric peaks of carboxylate ion were observed at
1600 and 1400 cm-1 coincide with the one observed in
amino acids (Wright & Vanderkooi 1997) and NH3
+
bending at 1550 cm-1 conclude that the gabapentin ex-
ists in zwitterionic form. Our studies match up to the
already reported infrared absorptions of gabapentin
(Chimatadar et al. 2007).
NIN produced two broad bands at 3300 and 3250 cm-1
and a C-O stretching at 1061 cm−1 signify the presence
of two OH groups. The carbonyl gave two peaks in the
region 1660 to 1760 cm−1. Aromatic resonance appeared
at 750 cm−1 (Arayne et al. 2008; Charles & Pouchert
1989; Charles & Pouchert 1981).
Primary amines to give Ruhemann’s Purple complex
with NIN (Arayne et al. 2008). The formation of the
complex was evidenced by comparing the spectra of
complex with parent reactant. Many of the functional-
ities of NIN and gabapentin were found absent which
confirms the formation of complex. The doublet ofTable 6 Recovery of Gabapentin in presence of different
excipient
Pyrro Lactose Talc Mag Stea Starch HPMC
Initial Rate 99.46 99.39 100.26 99.87 101.2 98.96
Rate Constant 98.92 100.66 100.33 99.55 101.47 99.1
Fixed Time 100.43 99.24 101.27 98.92 99.37 100.84carbonyl in NIN changed significantly into one single
sharp peak at 1680 cm-1 and the broad band of O-H
shifted to 3400 cm-1.
Nuclear magnetic resonance spectra
The 1H NMR spectra of gabapentin showed two –CH2
peaks at Δ 2.443 and Δ 2.873 ppm and the cyclohexyl
protons appeared in the region of Δ 1.365–1.585 ppm.
The likely peak of NH2 near Δ 2 ppm and that of car-
boxylic OH near Δ 11 ppm were not observed but one
peak of NH3+ at 4.849 Δ ppm was observed, may be as
suggested earlier, due to zwitterion formation. Same is
also reported in literature (Chimatadar et al. 2007). NIN
exhibited two singlets at Δ 7.240 and Δ 7.446 ppm for
the four protons of the aromatic group and a singlet at
Δ 1.52 ppm for two protons of the OH group. This coin-
cides with the reported studies (Arayne et al. 2008;
Charles & Pouchert 1981). By studying the 1H-NMR
spectrum of the gaba-NIN complex it was found that
the NH2 protons completely diminished and the broad
multiplet appearing between Δ 7.42 and Δ 8.163 ppm
showing eight aromatic CH protons. A singlet at Δ
4.803 ppm represents the enolic OH proton. The above
results were found in accord with UV and IR spectra,
confirming the proposed structure.
Conclusion
The data given above divulge that the proposed methods
are easy, accurate and sensitive with good precision and
accuracy. With these methods, one can do the analysis
with pace at low cost without losing accuracy. The pro-
posed methods can be used as alternative methods to
the reported ones for the routine determination of
gabapentin in pharmaceutical formulations. This encour-
ages their successful use in routine analysis of these
drugs in quality control laboratories.
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